Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition
Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization
Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement
Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms
Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value
Exousia Pro Announces Breakthrough In Exosome-Based Delivery
Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA
Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes
Exousia Pro Reports Positive Outcome in Legal Proceeding
Exousia Pro Files Provisional Patent for Novel Extracellular Vesicle Loading Method, Tapping into Multi-Billion Dollar Markets
Exousia Pro Announces Strategic Acquisition to Launch a New Telehealth Division
Exousia Pro Creates New Subdivisions
Exousia Pro Files Reg A.
Exousia Pro Expands its Scientific Advisory Board
Exousia Pro Will Launch a Web Series with Our New Consultant
Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application
Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview
Exousia Pro Offers Guidance on New Subdivisions
Exousia Pro to Deliver 500 Billion Dried Exosomes for Trade Show
Exousia Pro Issues Update on Name Change
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.